AFRICAN COUNTRY INTRODUCES HIV PREVENTION INJECTION THAT LASTS TWO MONTHS.

Zimbabwe has devised a novel HIV preventive injection.
The injection is intended to keep the receiver from developing the sickness for the next two months.

The medicine known as injectable cabotegravir (CAB_LA), which is currently available for pre-exposure prophylaxis (PrEP), is a cutting-edge biomedical strategy that provides a straightforward and potent means of preventing HIV transmission among people who are at high risk.

Unlike the conventional daily pill regimen necessary for PrEP, this injection is given once every two months, making it a more practical and manageable choice for people looking to safeguard against the virus.

Speaking on the development via X, Dr Misheck Ruwende, a renowned figure in the medical community said, “Good news! Zimbabwe had its first recipient of the HIV prevention injection today. A more convenient alternative to daily pills (PrEP). The injection is administered once in two months.”

Furthermore, the injection is not yet available at public hospitals and is currently accessible through Population Solutions for Health at New Start Centres.

The debut of CAB_LA has generated a wave of excitement and curiosity among the Zimbabwean populace.

Social media platforms are buzzing with discussions and opinions, with some users humorously comparing the injection to a ‘Depo’ shot, while others seek clarity on its availability, potential side effects, and the implications for treatment guidelines.

Although the HIV prevention injection is available for free, its availability is still very limited. It is not yet clear what specific criteria are being used to select individuals who receive the injection.